NEW YORK/LONDON (Reuters) - Amgen Inc, the world's largest biotech company, had offered to acquire Human Genome Sciences Inc for $35 per share two years ago, but the preliminary $7 billion bid was rejected by its smaller U.S. rival, two people familiar with the situation said on Thursday.

crab trap fernandina alaskan crab fishing game annual car accident deaths
No comments:
Post a Comment